Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome

Lipid-lowering effect of maize-based traditional Mexican food on a metabolic syndrome model in rats

(2013) Juan Manuel Muñoz Cano et al.   Lipids in Health and Disease

The effects of running exercise on oxidative capacity and PGC-1α mRNA levels in the soleus muscle of rats with metabolic syndrome

(2012) Fumiko Nagatomo et al.   Journal of Physiological Sciences

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

(2012) L. Azoulay et al.   BMJ-British Medical Journal

Differential Effects of Acute (Extenuating) and Chronic (Training) Exercise on Inflammation and Oxidative Stress Status in an Animal Model of Type 2 Diabetes Mellitus

(2011) Edite Teixeira de Lemos et al.   MEDIATORS OF INFLAMMATION

Serum Visfatin and Fetuin-A Levels and Glycemic Control in Patients with Obese Type 2 Diabetes Mellitus

(2011) Fethiye Oztop Gunduz et al.   Diabetes & Metabolism Journal

Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation

(2010) Massimo Collino et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of the peroxisome proliferator-activated receptor (PPAR)-γ agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals

(2010) A. Zanchi et al.   DIABETOLOGIA

Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice

(2010) Masaya Fukuda et al.   JOURNAL OF HYPERTENSION

Mechanisms Linking Obesity, Chronic Kidney Disease, and Fatty Liver Disease: The Roles of Fetuin-A, Adiponectin, and AMPK

(2010) J. H. Ix et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Fluid compartmental shifts with efficacious pioglitazone therapy in overweight monkeys: implications for peroxisome proliferator-activated receptor–γ agonist use in prediabetes

(2010) Kylie Kavanagh et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Metabolic Syndrome Pandemic

(2008) Scott M. Grundy   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The Adiponectin Receptors AdipoR1 and AdipoR2 Activate ERK1/2 through a Src/Ras-Dependent Pathway and Stimulate Cell Growth†

(2008) Mi-Hye Lee et al.   BIOCHEMISTRY

Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome

(2008) A. K. Gupta et al.   DIABETES OBESITY & METABOLISM

Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss

(2008) Thomas Reinehr et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adiponectin, Diabetes, and Coronary Heart Disease in Older Persons: Unraveling the Paradox

(2008) Naveed Sattar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of the PPARγ activator pioglitazone on p38 MAP kinase and IκBα in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis

(2008) Noriyuki Shibata et al.   NEUROPATHOLOGY

Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production

(2008) Anita M. Hennige et al.   PLoS One

Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis

(2008) Meriem Koufany et al.   ARTHRITIS RESEARCH & THERAPY